| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $199,800 | 1 | 2 |
Sells | $15,441,837 | 42 | 98 |
| COHEN RAYMOND W | director | 1 | $199,800 | 1 | $97,504 | $102,296 |
| Reilly Kevin C | director | 0 | $0 | 1 | $73,677 | $-73,677 |
| Kwo Elizabeth | director | 0 | $0 | 1 | $97,268 | $-97,268 |
| Schwartz Jeffrey Lawrence | 0 | $0 | 1 | $97,942 | $-97,942 | |
| Ladone Mary Kay | director | 0 | $0 | 1 | $98,464 | $-98,464 |
| Hanley Conor | director | 0 | $0 | 1 | $143,779 | $-143,779 |
| Moran Timothy P. | Chief Business Officer | 0 | $0 | 3 | $348,311 | $-348,311 |
| Ford Alfred J Jr | Chief Commercial Officer | 0 | $0 | 4 | $793,664 | $-793,664 |
| Mahboob Vaseem | Chief Financial Officer | 0 | $0 | 8 | $3.68M | $-3.68M |
| Umberger Traci S | See Remarks | 0 | $0 | 7 | $4.5M | $-4.5M |
| Webster Brian Daniel | See Remarks | 0 | $0 | 14 | $5.51M | $-5.51M |
Kestra Medical Technologies, Ltd. operates at the intersection of wearable medical technology and digital healthcare. Its core mission is to revolutionize patient outcomes in cardiovascular disease through intelligent, intuitive, and connected monitoring and therapeutic intervention solutions. The company's flagship offering is the Cardiac Recovery System (CRS) platform, which it develops and commercializes. This unified solution seamlessly integrates cardiac monitoring, therapeutic treatment, digital health capabilities, and patient support …
Over the last 12 months, insiders at Kestra Medical Technologies, Ltd. have bought $199,800 and sold $15.44M worth of Kestra Medical Technologies, Ltd. stock.
On average, over the past 5 years, insiders at Kestra Medical Technologies, Ltd. have bought $529,150 and sold $15.44M worth of stock each year.
Highest buying activity among insiders over the last 12 months: COHEN RAYMOND W (director) — $199,800.
The last purchase of 10,000 shares for transaction amount of $199,800 was made by COHEN RAYMOND W (director) on 2026‑03‑26.
| 2026-10-29 | Sale | Mahboob Vaseem | Chief Financial Officer | 4,788 0.008% | $30.60 | $146,503 | -3.01% | |
| 2026-10-28 | Sale | Mahboob Vaseem | Chief Financial Officer | 39,903 0.0684% | $30.48 | $1.22M | -0.40% | |
| 2026-10-27 | Sale | Umberger Traci S | See Remarks | 30,000 0.0504% | $30.03 | $900,882 | -0.60% | |
| 2026-10-27 | Sale | Mahboob Vaseem | Chief Financial Officer | 34,809 0.0585% | $30.04 | $1.05M | -0.60% | |
| 2026-10-21 | Sale | Umberger Traci S | See Remarks | 100,000 0.1671% | $27.18 | $2.72M | +8.71% | |
| 2026-10-20 | Sale | Webster Brian Daniel | See Remarks | 15,000 0.0263% | $29.56 | $443,389 | +4.51% | |
| 2026-09-30 | Sale | COHEN RAYMOND W | director | 3,330 0.0059% | $29.28 | $97,504 | +0.04% | |
| 2026-09-21 | Sale | Kwo Elizabeth | director | 4,010 0.0068% | $24.26 | $97,268 | +13.56% | |
| 2026-09-08 | Sale | Ladone Mary Kay | director | 3,908 0.0066% | $25.20 | $98,464 | +5.80% | |
| 2026-09-08 | Sale | Schwartz Jeffrey Lawrence | 3,890 0.0065% | $25.18 | $97,942 | +5.80% | ||
| 2026-09-08 | Sale | Hanley Conor | director | 5,694 0.0096% | $25.25 | $143,779 | +5.80% | |
| 2026-09-08 | Sale | Reilly Kevin C | director | 2,932 0.0049% | $25.13 | $73,677 | +5.80% | |
| 2026-08-17 | Sale | Webster Brian Daniel | See Remarks | 15,000 0.0254% | $27.48 | $412,181 | -3.06% | |
| 2026-08-07 | Sale | Mahboob Vaseem | Chief Financial Officer | 26,287 0.0441% | $25.88 | $680,383 | +2.65% | |
| 2026-08-04 | Sale | Webster Brian Daniel | See Remarks | 51,900 0.0837% | $24.52 | $1.27M | +4.07% | |
| 2026-08-04 | Sale | Umberger Traci S | See Remarks | 3,580 0.0057% | $24.04 | $86,073 | +4.07% | |
| 2026-08-04 | Sale | Ford Alfred J Jr | Chief Commercial Officer | 6,275 0.0099% | $24.09 | $151,141 | +4.07% | |
| 2026-08-04 | Sale | Mahboob Vaseem | Chief Financial Officer | 6,995 0.0114% | $24.68 | $172,635 | +4.07% | |
| 2026-08-03 | Sale | Webster Brian Daniel | See Remarks | 13,017 0.0222% | $23.92 | $311,424 | +12.46% | |
| 2026-08-03 | Sale | Umberger Traci S | See Remarks | 7,590 0.0129% | $23.86 | $181,062 | +12.46% |
| Umberger Traci S | See Remarks | 195825 0.3288% | $5.68M | 1 | 7 | +13.15% |
| Ford Alfred J Jr | Chief Commercial Officer | 99564 0.1672% | $2.89M | 1 | 4 | +13.15% |
| COHEN RAYMOND W | director | 54790 0.092% | $1.59M | 2 | 1 | +13.15% |
$167,495 | 10 | 32.53% | $50.79M | |
$8,662,717 | 6 | -49.85% | $7.36M | |
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | $858,500 | 3 | 13.15% | $1.73B |
$773,064 | 3 | 25.52% | $7.16B | |
$34,477,719 | 2 | -9.33% | $51.35M |
| Increased Positions | 84 | +186.67% | 11M | +22.71% |
| Decreased Positions | 17 | -37.78% | 3M | -6.57% |
| New Positions | 34 | New | 4M | New |
| Sold Out Positions | 6 | Sold Out | 783,531 | Sold Out |
| Total Postitions | 112 | +148.89% | 56M | +16.14% |